Product
Solaraze
2 clinical trials
2 indications
Indication
Actinic KeratosisIndication
Skin CancerClinical trial
Prospective, Three-armed, Randomised, Double-blind Study to Evaluate the Efficacy and Safety of the Treatment of Mild and Moderate Actinic Keratosis With a 5% Potassium Hydroxide Solution (Solcera, Medical Device) Versus Placebo and Investigator-blinded Comparison With 3% Diclofenac Gel (Solaraze, Medicinal Product) (Regulated by the Laws for Both Medical Devices and Medicinal Products)Status: Completed, Estimated PCD: 2023-01-24
Clinical trial
A Randomized, Placebo-controlled, Double-blind, Phase II Chemoprevention Clinical Trial of Topical Diclofenac and DFMO in Subjects With a History of Skin CancerStatus: Active (not recruiting), Estimated PCD: 2024-11-01